Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD
批准号:
10584209
负责人:
Mary McGrae McDermott
金额:
$72.31万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2027-05-31
关键词:
AddressBeetsBehavioralBiologicalCharacteristicsClinicalClinical TrialsControl GroupsDisabled PersonsElderlyEnrollmentExerciseExercise TherapyExercise ToleranceFailureGuidelinesHealth PersonnelHomeImpairmentIsolated limb perfusionJuiceLegLower ExtremityMeasuresMedicareMethodsMuscle functionNitratesNitritesParticipantPatientsPerformancePeripheral arterial diseasePersonsPlacebosPlant RootsPlasmaPractice GuidelinesRandomizedRecommendationReportingResearch DesignSkeletal MuscleSupervisionSymptomsTestingTimeTravelWalkingWorkattentional controlbaseevidence based guidelinesexercise intensityexercise interventionfollow-upimprovedimproved mobilitymeteroptimal treatmentsphase II trialrandomized trialresponders and non-respondersstandard of caretreadmilltrial design
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD
Supervised exercise therapy (SET), consisting of treadmill exercise conducted 3 times/week at a center
in the presence of healthcare personnel, is first line therapy for people disabled by lower extremity peripheral
artery disease (PAD). However, travelling to a center for SET is burdensome. As of 2018, only 1.3% of
patients with Medicare and symptomatic PAD had enrolled in SET. Home-based exercise is more accessible
and less burdensome than SET. Yet, guidelines recommend SET over home-based exercise for PAD.
Clinical trials have identified three characteristics of home-based exercise interventions that are highly
effective for people with PAD: 1) incorporation of behavioral change methods; 2) regular contact with a coach,
and 3) an exercise intensity that elicits ischemic leg symptoms during exercise. Recently we reported in JAMA
that a home-based exercise intervention that included these characteristics significantly and meaningfully
improved 6-minute walk in PAD, compared to an attention control group. However, no randomized trials have
directly compared SET to a highly effective home-based exercise intervention for people with PAD. In addition,
45% of people with PAD do not meaningfully respond to exercise, defined as failure to improve six-minute walk
distance by > 20 meters (a clinically meaningful improvement). This phenomenon occurs for both supervised
and home-based exercise. Our Phase II trial showed that nitrate-rich beetroot juice, which increases plasma
nitrite, limb perfusion, and exercise intensity, significantly reduced rates of non-response to exercise,
compared to placebo, in PAD. Therefore, we will use a Sequential Multiple Assessment Randomized Trial
(SMART) to address two major barriers to benefit from exercise for PAD: First, the recommendation for
supervised exercise. Second, the lack of treatment for non-response to exercise in PAD.
In SMART Exercise for PAD, 250 participants with PAD will be randomized to home-based exercise or
SET for 12 weeks (Stage I). At 12-week follow-up, participants will be classified into ‘responders’ (> 20 meter
improvement in 6-minute walk) or ‘non-responders’ (< 20 meter improvement in 6-minute walk). In weeks 13-
24 (Stage II), all participants will continue their originally assigned exercise condition (SET or home-based),
and non-responders will be re-randomized to either augmentation with beetroot juice or placebo while
continuing their original exercise. We will test two primary hypotheses. First, whether our home-based
exercise intervention improves 6-minute walk more than SET at 12-week follow-up (Primary Aim #1). Second,
whether biologic augmentation of exercise with beetroot juice improves 6-minute walk in PAD patients
unresponsive to exercise after 12 weeks (Primary Aim #2). In Secondary and Exploratory Aims, we will identify
the optimal exercise strategy to maximize gains in walking distances for all patients with PAD, thereby
improving mobility in the millions of older people disabled by PAD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Far Red Light to Improve Functioning in PAD: the LIGHT PAD Trial
-
批准号:10572758
-
项目类别:
-
资助金额:$26.76万
-
财政年份:2023
-
负责人:Mary McGrae McDermott
-
依托单位:
Response to Exercise and Nitric Oxide in PAD: the RESIST PAD Trial
-
批准号:10656845
-
项目类别:
-
资助金额:$74.92万
-
财政年份:2023
-
负责人:Mary McGrae McDermott
-
依托单位:
ENhancing exercise with LIGHT to improve functioning in PAD: the ENLIGHTEN PAD Trial
-
批准号:10645929
-
项目类别:
-
资助金额:$26.75万
-
财政年份:2023
-
负责人:Mary McGrae McDermott
-
依托单位:
BEET root juice to reverse functional impairment in PAD: The BEET PAD Trial
-
批准号:10440812
-
项目类别:
-
资助金额:$73.98万
-
财政年份:2022
-
负责人:Mary McGrae McDermott
-
依托单位:
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD
-
批准号:10708097
-
项目类别:
-
资助金额:$67.16万
-
财政年份:2022
-
负责人:Mary McGrae McDermott
-
依托单位:
BEET root juice to reverse functional impairment in PAD: The BEET PAD Trial
-
批准号:10649671
-
项目类别:
-
资助金额:$65.7万
-
财政年份:2022
-
负责人:Mary McGrae McDermott
-
依托单位:
FIsetin to Reduce Senescence and mobility impairmenT in PAD: the FIRST Pilot Randomized Trial
-
批准号:10526851
-
项目类别:
-
资助金额:$22.25万
-
财政年份:2022
-
负责人:Mary McGrae McDermott
-
依托单位:
COCOA flavanols to improve walking performance in PAD: the COCOA-PAD II Trial
-
批准号:10430199
-
项目类别:
-
资助金额:$63.45万
-
财政年份:2021
-
负责人:Mary McGrae McDermott
-
依托单位:
COCOA flavanols to improve walking performance in PAD: the COCOA-PAD II Trial
-
批准号:10685352
-
项目类别:
-
资助金额:$58.37万
-
财政年份:2021
-
负责人:Mary McGrae McDermott
-
依托单位:
COCOA flavanols to improve walking performance in PAD: the COCOA-PAD II Trial
-
批准号:10209585
-
项目类别:
-
资助金额:$70.87万
-
财政年份:2021
-
负责人:Mary McGrae McDermott
-
依托单位:
COCOA PAD II Trial: Microbiome Ancillary Study
-
批准号:10610072
-
项目类别:
-
资助金额:$18.3万
-
财政年份:2021
-
负责人:Mary McGrae McDermott
-
依托单位:
Pilot/Exploratory Studies Core (PESC)
-
批准号:10455653
-
项目类别:
-
资助金额:$44.46万
-
财政年份:2020
-
负责人:Mary McGrae McDermott
-
依托单位:
Pilot/Exploratory Studies Core (PESC)
-
批准号:10220722
-
项目类别:
-
资助金额:$43.17万
-
财政年份:2020
-
负责人:Mary McGrae McDermott
-
依托单位:
APelin, EXercise, and mobility in Peripheral Artery Disease, the APEX-PAD Study
-
批准号:10092068
-
项目类别:
-
资助金额:$13.88万
-
财政年份:2020
-
负责人:Mary McGrae McDermott
-
依托单位:
Pilot/Exploratory Studies Core (PESC)
-
批准号:10670210
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2020
-
负责人:Mary McGrae McDermott
-
依托单位:
1/2 + PROmote weight loss in obese PAD patients to preVEnt mobility loss: the PROVE Trial
-
批准号:10633185
-
项目类别:
-
资助金额:$65.01万
-
财政年份:2019
-
负责人:Mary McGrae McDermott
-
依托单位:
ConProject-001
-
批准号:10633186
-
项目类别:
-
资助金额:$3.36万
-
财政年份:2019
-
负责人:Mary McGrae McDermott
-
依托单位:
Unacylated Ghrelin to Improve FuncTioning in PAD: the GIFT Trial
-
批准号:9927974
-
项目类别:
-
资助金额:$20.22万
-
财政年份:2019
-
负责人:Mary McGrae McDermott
-
依托单位:
1/2 + PROmote weight loss in obese PAD patients to preVEnt mobility loss: the PROVE Trial
-
批准号:10026434
-
项目类别:
-
资助金额:$64.26万
-
财政年份:2019
-
负责人:Mary McGrae McDermott
-
依托单位:
1/2 + PROmote weight loss in obese PAD patients to preVEnt mobility loss: the PROVE Trial
-
批准号:10259851
-
项目类别:
-
资助金额:$66.4万
-
财政年份:2019
-
负责人:Mary McGrae McDermott
-
依托单位:
海外基金